alendronate has been researched along with Urinary Calculi in 6 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Urinary Calculi: Low-density crystals or stones in any part of the URINARY TRACT. Their chemical compositions often include CALCIUM OXALATE, magnesium ammonium phosphate (struvite), CYSTINE, or URIC ACID.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Osteoporosis is associated with the pathogenesis and risk of urolithiasis, which is higher among postmenopausal women (as opposed to premenopausal)." | 5.35 | Alendronate reduces the excretion of risk factors for calcium phosphate stone formation in postmenopausal women with osteoporosis. ( Hamamoto, S; Hirose, M; Itoh, Y; Kobayashi, T; Kohri, K; Okada, A; Tozawa, K; Yasui, T, 2009) |
| "Osteoporosis is associated with the pathogenesis and risk of urolithiasis, which is higher among postmenopausal women (as opposed to premenopausal)." | 1.35 | Alendronate reduces the excretion of risk factors for calcium phosphate stone formation in postmenopausal women with osteoporosis. ( Hamamoto, S; Hirose, M; Itoh, Y; Kobayashi, T; Kohri, K; Okada, A; Tozawa, K; Yasui, T, 2009) |
| "Urinary stones are similar to bone diseases such as osteoporosis and bone metabolism in terms of pathogenesis." | 1.32 | Alendronate inhibits urinary calcium microlith formation in a three-dimensional culture model. ( Ito, Y; Kohri, K; Okada, A; Senzaki, H; Tozawa, K; Yasui, T, 2004) |
| "Alendronate was administered to rats made hypercalcemic by treatment with parathyroid hormone-related peptide (PTHrP)." | 1.30 | Alendronate inhibits osteopontin expression enhanced by parathyroid hormone-related peptide (PTHrP) in the rat kidney. ( Azuma, Y; Fujita, K; Hirota, S; Iguchi, M; Kohri, K; Nomura, S; Ohta, T; Sasaki, S; Yasui, T, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yasui, T | 3 |
| Itoh, Y | 1 |
| Okada, A | 2 |
| Hamamoto, S | 1 |
| Hirose, M | 1 |
| Kobayashi, T | 1 |
| Tozawa, K | 2 |
| Kohri, K | 3 |
| Bereket, A | 1 |
| Erdogan, T | 1 |
| Senzaki, H | 1 |
| Ito, Y | 1 |
| Ruml, LA | 1 |
| Dubois, SK | 1 |
| Roberts, ML | 1 |
| Pak, CY | 1 |
| Weisinger, JR | 1 |
| Alonzo, E | 1 |
| Machado, C | 1 |
| Carlini, R | 1 |
| Martinis, R | 1 |
| Paz-MartÃnez, V | 1 |
| BellorÃn-Font, E | 1 |
| Fujita, K | 1 |
| Sasaki, S | 1 |
| Iguchi, M | 1 |
| Hirota, S | 1 |
| Nomura, S | 1 |
| Azuma, Y | 1 |
| Ohta, T | 1 |
1 trial available for alendronate and Urinary Calculi
| Article | Year |
|---|---|
Prevention of hypercalciuria and stone-forming propensity during prolonged bedrest by alendronate.
Topics: Adult; Alendronate; Bed Rest; Biomarkers; Bone and Bones; Bone Density; Calcium; Diphosphonates; Dou | 1995 |
5 other studies available for alendronate and Urinary Calculi
| Article | Year |
|---|---|
Alendronate reduces the excretion of risk factors for calcium phosphate stone formation in postmenopausal women with osteoporosis.
Topics: Alendronate; Bone Density Conservation Agents; Calcium Phosphates; Female; Humans; Middle Aged; Oste | 2009 |
Oral bisphosphonate therapy for vitamin D intoxication of the infant.
Topics: Administration, Oral; Alendronate; Bone Diseases; Hand; Humans; Hypercalcemia; Iatrogenic Disease; I | 2003 |
Alendronate inhibits urinary calcium microlith formation in a three-dimensional culture model.
Topics: Agar; Alendronate; Animals; Calcium Oxalate; Calcium Phosphates; Cell Culture Techniques; Cells, Cul | 2004 |
[Role of bones in the physiopathology of idiopathic hypercalciuria: effect of amino-bisphosphonate alendronate].
Topics: Alendronate; Bone and Bones; Bone Density; Bone Resorption; Calcium; Cytokines; Humans; Hydroxyproli | 1997 |
Alendronate inhibits osteopontin expression enhanced by parathyroid hormone-related peptide (PTHrP) in the rat kidney.
Topics: Alendronate; Animals; Blotting, Northern; Diphosphonates; Gene Expression; Hypercalcemia; Kidney; Ma | 1998 |